NextCompany

Established Life Sciences Manufacturer and Distributor

Fetal bovine serum manufacturer and distributor in the United States

On NextCompany since August 30, 2026 (45 days)

Location undisclosedEstablished 20004 FT employees
Financial summary
Asking price
$5,000,000
Gross revenue
$2,681,280
Cash flow (SDE)
$547,190
Inventory
$807,317
FF&E
$84,560

Figures come from the listing party and are not verified or guaranteed by NextCompany. Parts of this page are AI-generated and may contain errors. Verify everything before relying on it. See the Buyer Terms.

Business overview

This company manufactures fetal bovine serum and related bovine-derived products in the United States. Cell culture labs and biopharma plants use those products as supplements. The firm also distributes laboratory consumables that those labs order with serum. University labs, government labs, and biotechnology companies buy from the business. The business began in 2000. The owner is selling for retirement. Four employees run operations. The asking price is $5,000,000.

Who is a good fit for this business

  • Buyers seeking a United States manufacturer of fetal bovine serum and lab consumables.
  • Strategic acquirers that serve research labs or cell and gene therapy manufacturers.
  • Buyers who can fund a $5,000,000 asking price with a $2,500,000 down payment.
  • Operators who can lead a four-person manufacturing and distribution team.

Details

Reason for selling
Retirement

Frequently Asked Questions

The company manufactures fetal bovine serum and related bovine-derived products. Cell culture labs and biopharmaceutical manufacturers use those products as supplements. The firm also distributes laboratory consumables that research teams use with serum. University labs, government labs, and biotechnology companies buy on a repeat basis.

The business operates in the United States. It makes fetal bovine serum and related bovine-derived products there. It also distributes laboratory consumables to research and therapy customers. The business is not relocatable.

The asking price is $5,000,000. Gross revenue is $2,681,280. Seller's discretionary earnings are $547,190. The listing also names a $2,500,000 down payment.

Inventory stands at $807,317. Furniture, fixtures, and equipment total $84,560. Four employees run the company. The sale covers this operating life sciences manufacturer and distributor.

Retirement is the reason for the sale. The business began in 2000. Four employees run operations today. Taylor Bryner lists the company with Transworld Business Advisors of Colorado.

Similar businesses